Patents by Inventor Radhika Muzumdar

Radhika Muzumdar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of myocardial injury with humanin analogs
    Patent number: 9034825
    Abstract: Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: May 19, 2015
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Radhika Muzumdar, David J. Lefer
  • TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF
    Publication number: 20140179610
    Abstract: Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
    Type: Application
    Filed: February 21, 2014
    Publication date: June 26, 2014
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Radhika Muzumdar, David J. Lefer
  • Humanin Decreases Liver Fat and Visceral Fat Accumulation
    Publication number: 20130109635
    Abstract: Methods are provided for reducing visceral fat or reducing accumulation of visceral fat in a subject, or of reducing fat in a liver or reducing accumulation of fat in a liver of a subject, comprising administering a humanin or an active analog of humanin to the subject. Methods are also provided of increasing hepatic triglyceride secretion in a subject or of increasing hepatic microsomal triglyceride transfer protein (MTTP) expression in a subject.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 2, 2013
    Inventor: Radhika Muzumdar
  • TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF
    Publication number: 20130045916
    Abstract: Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
    Type: Application
    Filed: October 9, 2012
    Publication date: February 21, 2013
    Applicants: The Regeants of the University of California, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Nir Barzilai, Pinchas Cohen, Radhika Muzumdar, David Lefer
  • Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
    Patent number: 8309525
    Abstract: Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
    Type: Grant
    Filed: May 28, 2008
    Date of Patent: November 13, 2012
    Assignees: Albert Einstein College of Medicine of Yeshiva University, The Regents of the University of California
    Inventors: Nir Barzilai, Pinchas Cohen, Radhika Muzumdar
  • TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF
    Publication number: 20100204099
    Abstract: Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
    Type: Application
    Filed: May 28, 2008
    Publication date: August 12, 2010
    Inventors: Nir Barzilai, Pinchas Cohen, Radhika Muzumdar, David Lefer